Composition
- Active ingredients
- GRISEOFULVIN, MICROCRYSTALLINE 500MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GRISEOFULVIN, MICROCRYSTALLINE 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletANDA062279-002 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 125MG · TabletANDA062279-001 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SuspensionNDA050448-001 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 250MG · TabletANDA060618-002 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 500MG · TabletThis page
- GRISEOFULVIN, MICROCRYSTALLINE 125MG · TabletANDA060618-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA060618.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Grifulvin V
- Active substance
- griseofulvin, microcrystalline
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- J and J
- Status
- Discontinued
- FDA approval
- 14 Jul 1971
- Application
- ANDA060618-003